Changes in the pattern of Kaposi’s sarcoma at Ocean Road Cancer Institute in Tanzania (2006–2011)

Lia Koski, Twalib Ngoma, Julius Mwaiselage, Lynne Le, Amr S. Soliman

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Tanzania has high human immunodeficiency virus and human herpes virus-8 rates linked to Kaposi’s sarcoma. We conducted a study at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania to examine changes in proportions of Kaposi’s sarcoma to all cancers over the period (2006–2011) of increased acquired immune deficiency syndrome management by anti-retroviral therapy. We included 1504 Kaposi’s sarcoma cases from Ocean Road Cancer Institute and abstracted information regarding age, gender, human immunodeficiency virus and tuberculosis, anti-retroviral therapy duration and Kaposi’s sarcoma lesions. Male Kaposi’s sarcoma patients (59.6%) were older (42.1 ± 11.5 years) than women (40.4%) (36.2 ± 9.6 years). Kaposi’s sarcoma proportions declined from 10.1% in 2003 to 7.4% in 2011. Being a woman was associated with increased oral and generalized lesions and higher numbers of lesion locations (odds ratio [OR] = 2.17, 95% confidence interval [CI]: 1.35, 3.51; OR = 1.49, CI: 1.08, 2.06; OR = 1.06, CI: 0.79, 1.41, respectively). Tuberculosis was associated with oral, generalized and number of lesion locations (OR = 2.08, CI: 1.10, 3.93; OR = 2.06, CI: 1.28, 3.33; OR = 1.88, CI: 1.19, 2.97, respectively). Anti-retroviral therapy duration showed a protective effect with oral, generalized and number of lesion locations (OR = 0.55, CI: 0.33, 0.91; OR = 0.73, CI: 0.52, 1.01; OR = 0.89, CI: 0.67, 1.18, respectively). With increasing number of patients receiving prolonged anti-retroviral therapy, future studies should investigate long-term effect of anti-retroviral therapy and tuberculosis in Tanzania and countries with human immunodeficiency virus infection.

Original languageEnglish (US)
Pages (from-to)470-478
Number of pages9
JournalInternational Journal of STD and AIDS
Volume26
Issue number7
DOIs
StatePublished - Jun 9 2015

Fingerprint

Tanzania
Kaposi's Sarcoma
Oceans and Seas
Odds Ratio
Confidence Intervals
Neoplasms
Tuberculosis
HIV
Therapeutics
Virus Diseases
Acquired Immunodeficiency Syndrome
Viruses

Keywords

  • AIDS
  • HHV-8
  • HIV
  • Human immunodeficiency virus
  • Kaposi’s sarcoma
  • Tanzania
  • antiretroviral therapy
  • cancer
  • human herpes virus-8
  • trend

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Changes in the pattern of Kaposi’s sarcoma at Ocean Road Cancer Institute in Tanzania (2006–2011). / Koski, Lia; Ngoma, Twalib; Mwaiselage, Julius; Le, Lynne; Soliman, Amr S.

In: International Journal of STD and AIDS, Vol. 26, No. 7, 09.06.2015, p. 470-478.

Research output: Contribution to journalArticle

Koski, Lia ; Ngoma, Twalib ; Mwaiselage, Julius ; Le, Lynne ; Soliman, Amr S. / Changes in the pattern of Kaposi’s sarcoma at Ocean Road Cancer Institute in Tanzania (2006–2011). In: International Journal of STD and AIDS. 2015 ; Vol. 26, No. 7. pp. 470-478.
@article{48a3f74b00ab4ed18f05037b12d9ddd1,
title = "Changes in the pattern of Kaposi’s sarcoma at Ocean Road Cancer Institute in Tanzania (2006–2011)",
abstract = "Tanzania has high human immunodeficiency virus and human herpes virus-8 rates linked to Kaposi’s sarcoma. We conducted a study at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania to examine changes in proportions of Kaposi’s sarcoma to all cancers over the period (2006–2011) of increased acquired immune deficiency syndrome management by anti-retroviral therapy. We included 1504 Kaposi’s sarcoma cases from Ocean Road Cancer Institute and abstracted information regarding age, gender, human immunodeficiency virus and tuberculosis, anti-retroviral therapy duration and Kaposi’s sarcoma lesions. Male Kaposi’s sarcoma patients (59.6{\%}) were older (42.1 ± 11.5 years) than women (40.4{\%}) (36.2 ± 9.6 years). Kaposi’s sarcoma proportions declined from 10.1{\%} in 2003 to 7.4{\%} in 2011. Being a woman was associated with increased oral and generalized lesions and higher numbers of lesion locations (odds ratio [OR] = 2.17, 95{\%} confidence interval [CI]: 1.35, 3.51; OR = 1.49, CI: 1.08, 2.06; OR = 1.06, CI: 0.79, 1.41, respectively). Tuberculosis was associated with oral, generalized and number of lesion locations (OR = 2.08, CI: 1.10, 3.93; OR = 2.06, CI: 1.28, 3.33; OR = 1.88, CI: 1.19, 2.97, respectively). Anti-retroviral therapy duration showed a protective effect with oral, generalized and number of lesion locations (OR = 0.55, CI: 0.33, 0.91; OR = 0.73, CI: 0.52, 1.01; OR = 0.89, CI: 0.67, 1.18, respectively). With increasing number of patients receiving prolonged anti-retroviral therapy, future studies should investigate long-term effect of anti-retroviral therapy and tuberculosis in Tanzania and countries with human immunodeficiency virus infection.",
keywords = "AIDS, HHV-8, HIV, Human immunodeficiency virus, Kaposi’s sarcoma, Tanzania, antiretroviral therapy, cancer, human herpes virus-8, trend",
author = "Lia Koski and Twalib Ngoma and Julius Mwaiselage and Lynne Le and Soliman, {Amr S.}",
year = "2015",
month = "6",
day = "9",
doi = "10.1177/0956462414544724",
language = "English (US)",
volume = "26",
pages = "470--478",
journal = "International Journal of STD and AIDS",
issn = "0956-4624",
publisher = "SAGE Publications Ltd",
number = "7",

}

TY - JOUR

T1 - Changes in the pattern of Kaposi’s sarcoma at Ocean Road Cancer Institute in Tanzania (2006–2011)

AU - Koski, Lia

AU - Ngoma, Twalib

AU - Mwaiselage, Julius

AU - Le, Lynne

AU - Soliman, Amr S.

PY - 2015/6/9

Y1 - 2015/6/9

N2 - Tanzania has high human immunodeficiency virus and human herpes virus-8 rates linked to Kaposi’s sarcoma. We conducted a study at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania to examine changes in proportions of Kaposi’s sarcoma to all cancers over the period (2006–2011) of increased acquired immune deficiency syndrome management by anti-retroviral therapy. We included 1504 Kaposi’s sarcoma cases from Ocean Road Cancer Institute and abstracted information regarding age, gender, human immunodeficiency virus and tuberculosis, anti-retroviral therapy duration and Kaposi’s sarcoma lesions. Male Kaposi’s sarcoma patients (59.6%) were older (42.1 ± 11.5 years) than women (40.4%) (36.2 ± 9.6 years). Kaposi’s sarcoma proportions declined from 10.1% in 2003 to 7.4% in 2011. Being a woman was associated with increased oral and generalized lesions and higher numbers of lesion locations (odds ratio [OR] = 2.17, 95% confidence interval [CI]: 1.35, 3.51; OR = 1.49, CI: 1.08, 2.06; OR = 1.06, CI: 0.79, 1.41, respectively). Tuberculosis was associated with oral, generalized and number of lesion locations (OR = 2.08, CI: 1.10, 3.93; OR = 2.06, CI: 1.28, 3.33; OR = 1.88, CI: 1.19, 2.97, respectively). Anti-retroviral therapy duration showed a protective effect with oral, generalized and number of lesion locations (OR = 0.55, CI: 0.33, 0.91; OR = 0.73, CI: 0.52, 1.01; OR = 0.89, CI: 0.67, 1.18, respectively). With increasing number of patients receiving prolonged anti-retroviral therapy, future studies should investigate long-term effect of anti-retroviral therapy and tuberculosis in Tanzania and countries with human immunodeficiency virus infection.

AB - Tanzania has high human immunodeficiency virus and human herpes virus-8 rates linked to Kaposi’s sarcoma. We conducted a study at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania to examine changes in proportions of Kaposi’s sarcoma to all cancers over the period (2006–2011) of increased acquired immune deficiency syndrome management by anti-retroviral therapy. We included 1504 Kaposi’s sarcoma cases from Ocean Road Cancer Institute and abstracted information regarding age, gender, human immunodeficiency virus and tuberculosis, anti-retroviral therapy duration and Kaposi’s sarcoma lesions. Male Kaposi’s sarcoma patients (59.6%) were older (42.1 ± 11.5 years) than women (40.4%) (36.2 ± 9.6 years). Kaposi’s sarcoma proportions declined from 10.1% in 2003 to 7.4% in 2011. Being a woman was associated with increased oral and generalized lesions and higher numbers of lesion locations (odds ratio [OR] = 2.17, 95% confidence interval [CI]: 1.35, 3.51; OR = 1.49, CI: 1.08, 2.06; OR = 1.06, CI: 0.79, 1.41, respectively). Tuberculosis was associated with oral, generalized and number of lesion locations (OR = 2.08, CI: 1.10, 3.93; OR = 2.06, CI: 1.28, 3.33; OR = 1.88, CI: 1.19, 2.97, respectively). Anti-retroviral therapy duration showed a protective effect with oral, generalized and number of lesion locations (OR = 0.55, CI: 0.33, 0.91; OR = 0.73, CI: 0.52, 1.01; OR = 0.89, CI: 0.67, 1.18, respectively). With increasing number of patients receiving prolonged anti-retroviral therapy, future studies should investigate long-term effect of anti-retroviral therapy and tuberculosis in Tanzania and countries with human immunodeficiency virus infection.

KW - AIDS

KW - HHV-8

KW - HIV

KW - Human immunodeficiency virus

KW - Kaposi’s sarcoma

KW - Tanzania

KW - antiretroviral therapy

KW - cancer

KW - human herpes virus-8

KW - trend

UR - http://www.scopus.com/inward/record.url?scp=84988287141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988287141&partnerID=8YFLogxK

U2 - 10.1177/0956462414544724

DO - 10.1177/0956462414544724

M3 - Article

C2 - 25080290

AN - SCOPUS:84988287141

VL - 26

SP - 470

EP - 478

JO - International Journal of STD and AIDS

JF - International Journal of STD and AIDS

SN - 0956-4624

IS - 7

ER -